| Literature DB >> 19838367 |
Abstract
The availability of fracture healing therapies to the general public is limited in India. The infrastructure of the health system in India, involving both public and private sectors, does not provide adequate opportunity for rural and low-income inhabitants to access needed care. Also the lack of funding from the government and the overall lack of physicians place a large strain on the system. This paper will take an in-depth look at the state of the current health care system and how it affects bone stimulation therapy in India. The Indian Journal of Orthopaedics was used as a reference for the bone stimulation therapies currently utilized in India. A general search of the therapies and technologies was performed to determine protocols and indications. A table of fracture healing therapies and technologies was composed which provides a description of each therapy, as well as its specific indications and protocols. This information was then used by the authors to hypothesize the most feasible methods of fracture healing to meet the Indian demographic. Based on an assessment of the health system of India, the most practical methods of bone stimulation therapy were determined. It was also determined that nearly all forms of therapy could be made available if sufficient resources were set aside for it. Bone stimulation therapy in India remains a large void in the health care system.Entities:
Keywords: Fracture healing; India; available therapies; bone stimulation; indications; protocols
Year: 2009 PMID: 19838367 PMCID: PMC2762263 DOI: 10.4103/0019-5413.50853
Source DB: PubMed Journal: Indian J Orthop ISSN: 0019-5413 Impact factor: 1.251
Fracture healing technologies
| Fracture healing therapy | Description | Indications | Protocols |
|---|---|---|---|
| Ultrasound therapy | Low-intensity ultrasound waves are used to stimulate bone growth. | It is used in situations of delayed unions and nonunions of bone fractures. | Ultrasound machine transducer is used in direct contact with the skin with an ultrasonic gel over the area of the fracture site. |
| Extracorporeal shock wave therapy | Pressure waves that tend to have high positive pressures with short wavelengths are used. | It is used in situations of delayed unions and nonunions of bone fractures. | Head of the shock wave device is placed on the skin over the fracture site; an ultrasonic gel is used. |
| Electrical stimulation herapy | Electrodes are placed in the bone and produce a direct, localized stimulation. | It is used in nonunions in large bones such as the femur and tibia and pseudoarthrosis. | A single or multiple electrodes are inserted into the bone via drilled holes. Holes are made in an oblique manner. |
Fracture healing therapies
| Fracture healing therapy | Description | Indications | Protocols |
|---|---|---|---|
| Bone morphogenetic protein (BMP) | It is a member of the transforming growth factor (TGF) family; the proteins are naturally produced in the body. | It is used in delayed unions and nonunions, as well as open fractures. | BMP (usually in a paste or microsphere state) is added to a carrier material that provides a matrix (maintains the volume of the space where bone growth will occur) and is able to maintain the concentration of BMP at the fracture site. |
| Carrier types include collagen; inorganic materials such as ceramics; and synthetic polymers such as glass. | |||
| Biphasic calcium phosphate (BCP) | BCP is a calcium phosphate compound that acts as a scaffold for bone to grow in and around. | It is used to treat bone defects and nonunions. | HA and TCP are combined to create the BCP. |
| Parathyroid hormone (PTH) | PTH is an anabolic hormone that is used to increase bone formation by increasing the efficiency of osteoblasts. | It is been approved by the FDA to treat postmenopausal women suffering from osteoporosis, who are at a high risk of fractures. | It can be utilized through subcutaneous injections. |
| Tissue engineering and gene therapy | Stem (mesenchymal) cells or other cells are used to increase the differentiation by | It is used in fresh fractures and nonunions. | Stem cells are removed from the patient via a biopsy and developed |
| Calcium sulfate | It has a very rapid resorption rate and for the most part is used as a composite with other bonestimulating agents such as HA or BMP. | It is used to repair any bone defects including those in the long bone, the cranium, and the spine. | Composites of calcium sulfate are entered into the bone voids. |
| Coralline | It is traditionally developed with a form of calcium phosphate, such as HA. | It is used to repair any bone defects. | Coralline and calcium phosphate are implanted at the fracture site. |
| Type I collagen | It is the scaffold carrier material that is introduced to the fracture site as a composite. | Used in segmental bone defects and most prominently in long-bone defects. | In its clinically available form, Type I collagen is mixed with 5% Type III collagen, and microparticles are formed. |
| Allografts or demineralized bone matrix (DBM) | DBM provides the mineral components required for bone growth. | Used in fresh fractures and nonunions. | Internal fixation must occur, which is then followed by grafting. |
Comparison of costs for advanced surgery in India, Thailand, and USA3
| Cost for treatment in each Country | |||
|---|---|---|---|
| Treatment | India | Thailand | USA |
| Bone marrow transplant | 30,000 | 62,500 | 250,000 |
| Open heart surgery (CABG) | 5,000–7,000 | 14,250 | 30,000 |
| Hip replacement | 4,500 | 6,900 | – |
| Knee surgery | 4,500 | 6,900 | 20,000 |
| Hysterectomy | 500 | 2,000 | – |
| Gall bladder removal | 555 | 1,755 | – |
Cost of surgery in specialized hospitals (private fospitals in India). Source: www.ibef.org
Disadvantages of an autogenous bone graft10
| Limited availability |
| Postoperative pain at the operative site |
| Potential injury to the lateral femoral cutaneous |
| Potential injury to superior gluteal artery |
| Postoperative hematoma |
| Potential for infection at the operative site |
| Possibility of the gait disturbance |
Features of an ideal bone graft substitute10
| Have results as good as or better than autograft in achieving union |
| Be cost effective |
| Have no immunogenicity |
| Have handling characteristics familiar to surgeons |
| Resorb with a predictable degradation time |
| Act locally without any or negligible systemic side effects |
| Be osteoconductive and osteoinductive with a potential of supplying |
| or attracting osteogenic cells |
| Not interfere with modern imaging modalities |
| Produce nonexothermic reaction when implanted so as to prevent |
| heat damage to antibiotics and growth factors |